⌘K

Login Start Free

Home/Filings/4/0001638599-18-000700

4//SEC Filing

Fink Jeffrey Arvin 4

Accession 0001638599-18-000700

CIK 0001535955other

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 12:29 PM ET

Size

5.2 KB

Accession

0001638599-18-000700

Insider Transaction Report

Form 4

Period: 2018-06-27

Lipocine Inc.LPCN

Fink Jeffrey Arvin

Director

Transactions

Award
Stock Option (Right to Buy)
2018-06-27$1.33/sh+20,000$26,600→ 20,000 total
Exercise: $1.33From: 2019-06-27Exp: 2028-06-27→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]100% vesting one year from date of grant

Documents

1 file

4
doc4_5502.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lipocine Inc.

CIK 0001535955

Entity typeother

Related Parties

1

filerCIK 0001595930

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 12:29 PM ET
Size: 5.2 KB

View on SEC.gov